1. Home
  2. GETY vs VYGR Comparison

GETY vs VYGR Comparison

Compare GETY & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Getty Images Holdings Inc.

GETY

Getty Images Holdings Inc.

N/A

Current Price

$0.41

Market Cap

253.5M

Sector

Industrials

ML Signal

N/A

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$3.09

Market Cap

203.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GETY
VYGR
Founded
1995
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.5M
203.6M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
GETY
VYGR
Price
$0.41
$3.09
Analyst Decision
Hold
Strong Buy
Analyst Count
3
2
Target Price
$3.78
$16.50
AVG Volume (30 Days)
5.3M
750.5K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$926,244,000.00
$10,135,000.00
Revenue This Year
$0.37
$34.04
Revenue Next Year
$1.47
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
0.82
N/A
52 Week Low
$0.42
$2.88
52 Week High
$3.21
$5.55

Technical Indicators

Market Signals
Indicator
GETY
VYGR
Relative Strength Index (RSI) 30.59 37.41
Support Level N/A $2.96
Resistance Level $0.93 $4.33
Average True Range (ATR) 0.06 0.18
MACD -0.03 -0.02
Stochastic Oscillator 8.00 13.69

Price Performance

Historical Comparison
GETY
VYGR

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: